Compound 1468
Identifiers
- Canonical SMILES:
CN(C)CCNC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1
- InChi:
InChI=1S/C29H31Cl2F2N7O2/c1-39(2)13-12-35-22(41)15-18-8-10-19(30)23(33)25(18)40-26(17-9-11-21(32)20(31)14-17)24(28-37-38-29(34)42-28)36-27(40)16-6-4-3-5-7-16/h8-11,14,16H,3-7,12-13,15H2,1-2H3,(H2,34,38)(H,35,41)
- InChiKey:
QXBRWTLNDSKJLD-UHFFFAOYSA-N
External links
![]() 168318086 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| MDM2-Like / P53 | 8.15 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 617.19 g/mol | |||
| HBA | 9 | |||
| HBD | 3 | |||
| HBA + HBD | 12 | |||
| AlogP | 4.46 | |||
| TPSA | 115.10 | |||
| RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| WO2011023677 | 512 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 8.15 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.4474 | Velpatasvir | DB11613 | |
| 0.4306 | Azeliragon | DB12689 | |
| 0.4112 | LY-2584702 | DB12690 | |
| 0.4110 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
| 0.4058 | AMG-510 | DB15569 | |
| 0.4045 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
| 0.3987 | Otenabant | DB11745 | |
| 0.3926 | Samatasvir | DB12660 | |
| 0.3916 | Elbasvir | DB11574 | |
| 0.3891 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
| 0.3849 | Ralimetinib | DB11787 | |
| 0.3839 | Ledipasvir | DB09027 | |
| 0.3839 | BMS-986142 | DB15291 | |
| 0.3830 | Selonsertib | DB14916 | |
| 0.3812 | Ubrogepant | DB15328 |




